Advertisement

Document › Details
Cellink AB. (3/11/21). "Press Release: Cellink AB Announces an Offering of Senior Unsecured Convertible Bonds Convertible into Class B Shares and a Class B Share Issue in an Expected Amount of SEK 2.75 Billion [NOT FOR US, CA, et al.]". Gothenburg.
Original document
accessed by [iito] on 2021-03-14
Record changed: 2021-03-14 |
Advertisement

More documents for Cellink (Group)
- [1] Scienion AG. (3/18/21). "Press Release: Gilupi and Scienion Announce Collaboration for the Development of Single-Cell CTC Analysis". Potsdam & Berlin....
- [2] Cellink AB. (3/12/21). "Press Release: Cellink AB (publ) Announces the Completion of the Offering of Senior Unsecured Convertible Bonds Convertible into Class B Shares and a Class B Share Issue in an Overall Amount of SEK 3.0 Billion [NOT FOR US, CA, AU,...
- [3] Cellink AB. (3/10/21). "Press Release: Cellink Has Entered into an Agreement to Acquire MatTek, the Global Leader in In-vitro Technology and Alternative Drug Testing Models"....
- [4] Cellink AB. (3/1/21). "Press Release: Cellink Completes the Acquisition of Ginolis Oy"....
- [5] Cellink AB. (2/15/21). "Press Release: Cellink Has Entered into an Agreement to Acquire the Advanced Robotics and Diagnostics Automation Company Ginolis"....
- [6] Scienion AG. (2/3/21). "Press Release: Scienion Continues to Grow and Will Build New Headquarters in Berlin Adlershof". Berlin....
- [7] Cellink AB. (8/28/20). "Press Release: Cellink Welcomes New Scientific Advisor Professor Ido Amit from the Weizmann Institute of Science". Gothenburg....
- [8] Cellink AB. (8/27/20). "Press Release: Cytena and AstraZeneca Collaborate to Develop Plate Based Microbioreactors for Cell Line Development Workflows"....
- [9] Scienion AG. (8/19/20). "Press Release: Cellink Has Entered into an Agreement to Acquire Precision Dispensing Company Scienion AG"....
- [10] Scienion AG. (6/22/20). "Press Release: Accurate Spike-in of Circulating Tumor Cells into Blood Samples is Essential for Reliable Analysis in Oncology Applications". Berlin, Lyon & Seattle, WA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top